tirzepatide sglt2 Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia in patients with type 2 diabetes: Real world evidence from a retrospective cohort study and anti SGLT2 Inhibitors and GLP-1 Receptor

CrossRef Thermogenic Modulation of Adipose Depots: A Perspective on Possible Therapeutic Intervention with Early Cardiorenal Complications of Metabolic Impairment Ahmed F

They work by mimicking the hormone, which is naturally released by the intestine after eating

GLP-1 medications, peptides, NAD, and even exosome therapies have moved from niche clinical research into popular discussion

He said, if you ask people, Would you rather take a pill or an injection? People overwhelmingly prefer a pill. He added, however, that people might not feel the same way if the pills are more costly than the injections

The trial included 60 adult participants (mean age approximately 49) who had clinical follow-up with labs every 2 months for up to 2 years, with some withdrawing early due to spontaneous remission, indication for definitive therapy (e.g., thyroidectomy or radioiodine), or an intolerance to the treatment